Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GoodRx Holdings, Inc.GDRX · Entity 4838 | Chief Accounting Officer | March 08, 2026 | March 09, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GoodRx Holdings, Inc.
Report date March 08, 2026 · Filed March 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 183,061 |
Ending reported balance
After 2026-03-08 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-03-08 · Exercise / conversion · Acquired 10,201 · Balance 185,949 F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Row 2 · 2026-03-08 · Tax withholding · Disposed 4,201 · Balance 181,748 Row 3 · 2026-03-08 · Exercise / conversion · Acquired 2,233 · Balance 183,981 F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Row 4 · 2026-03-08 · Tax withholding · Disposed 920 · Balance 183,061 |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 20,402 |
Reported balance
After 2026-03-08 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-03-08 · Exercise / conversion · Disposed 10,201 · Balance 20,402 F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 17,858 |
Reported balance
After 2026-03-08 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-03-08 · Exercise / conversion · Disposed 2,233 · Balance 17,858 F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F3: The restricted stock unit award will vest as to 6.25% of the underlying shares on June 8, 2024 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
F2: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters.
F3: The restricted stock unit award will vest as to 6.25% of the underlying shares on June 8, 2024 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 08, 2026 Filed Mar 9, 2026 17:19 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 2,233 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-26-000053 · wk-form4_1773091157.xml · derivative · entry 6 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,858 Underlying: Class A Common Stock · 2,233 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F3 · derivative.exercise_date: The restricted stock unit award will vest as to 6.25% of the underlying shares on June 8, 2024 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. F3 · derivative.expiration_date: The restricted stock unit award will vest as to 6.25% of the underlying shares on June 8, 2024 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| March 08, 2026 Filed Mar 9, 2026 17:19 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 10,201 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-26-000053 · wk-form4_1773091157.xml · derivative · entry 5 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,402 Underlying: Class A Common Stock · 10,201 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| March 08, 2026 Filed Mar 9, 2026 17:19 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 920 | $2.28 | $2,097.60 |
DisclosureSEC source: 0001809519-26-000053 · wk-form4_1773091157.xml · nonDerivative · entry 4 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,061 Read SEC document |
| March 08, 2026 Filed Mar 9, 2026 17:19 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 2,233 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-26-000053 · wk-form4_1773091157.xml · nonDerivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,981 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| March 08, 2026 Filed Mar 9, 2026 17:19 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 4,201 | $2.28 | $9,578.28 |
DisclosureSEC source: 0001809519-26-000053 · wk-form4_1773091157.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 181,748 Read SEC document |
| March 08, 2026 Filed Mar 9, 2026 17:19 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 10,201 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-26-000053 · wk-form4_1773091157.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| March 03, 2026 Filed Mar 5, 2026 20:09 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantRestricted Stock Unit · Derivative | 108,189 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-26-000046 · wk-form4_1772759395.xml · derivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,189 Underlying: Class A Common Stock · 108,189 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units will vest ratably in 12 equal quarterly installments, with the first vesting occurring on April 15, 2026, and subject to continued service through each applicable vesting date. F2 · derivative.expiration_date: The restricted stock units will vest ratably in 12 equal quarterly installments, with the first vesting occurring on April 15, 2026, and subject to continued service through each applicable vesting date. Read SEC document |
| February 15, 2026 Filed Feb 17, 2026 17:25 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 4,804 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-26-000013 · wk-form4_1771367122.xml · derivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,650 Underlying: Class A Common Stock · 4,804 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest as to 6.25% of the underlying shares on May 15, 2025 and the remaining 93.75% of the underlying shares to vest in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock units vest as to 6.25% of the underlying shares on May 15, 2025 and the remaining 93.75% of the underlying shares to vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| February 15, 2026 Filed Feb 17, 2026 17:25 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 1,979 | $2.18 | $4,314.22 |
DisclosureSEC source: 0001809519-26-000013 · wk-form4_1771367122.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,748 Read SEC document |
| February 15, 2026 Filed Feb 17, 2026 17:25 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 4,804 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-26-000013 · wk-form4_1771367122.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 177,727 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| February 08, 2026 Filed Feb 9, 2026 17:49 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 12,663 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-26-000010 · wk-form4_1770677373.xml · derivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,314 Underlying: Class A Common Stock · 12,663 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock units vest as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| February 08, 2026 Filed Feb 9, 2026 17:49 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 5,215 | $2.44 | $12,724.60 |
DisclosureSEC source: 0001809519-26-000010 · wk-form4_1770677373.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,923 Read SEC document |
| February 08, 2026 Filed Feb 9, 2026 17:49 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 12,663 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-26-000010 · wk-form4_1770677373.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 178,138 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| December 08, 2025 Filed Dec 8, 2025 18:28 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 2,232 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000152 · wk-form4_1765236481.xml · derivative · entry 6 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,091 Underlying: Class A Common Stock · 2,232 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F3 · derivative.exercise_date: The restricted stock unit award will vest as to 6.25% of the underlying shares on June 8, 2024 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. F3 · derivative.expiration_date: The restricted stock unit award will vest as to 6.25% of the underlying shares on June 8, 2024 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| December 08, 2025 Filed Dec 8, 2025 18:28 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 10,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000152 · wk-form4_1765236481.xml · derivative · entry 5 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,603 Underlying: Class A Common Stock · 10,200 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| December 08, 2025 Filed Dec 8, 2025 18:28 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 799 | $2.71 | $2,165.29 |
DisclosureSEC source: 0001809519-25-000152 · wk-form4_1765236481.xml · nonDerivative · entry 4 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,475 Read SEC document |
| December 08, 2025 Filed Dec 8, 2025 18:28 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 2,232 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-25-000152 · wk-form4_1765236481.xml · nonDerivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166,274 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| December 08, 2025 Filed Dec 8, 2025 18:28 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 3,650 | $2.71 | $9,891.50 |
DisclosureSEC source: 0001809519-25-000152 · wk-form4_1765236481.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,042 Read SEC document |
| December 08, 2025 Filed Dec 8, 2025 18:28 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 10,200 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-25-000152 · wk-form4_1765236481.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167,692 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| November 15, 2025 Filed Nov 17, 2025 17:27 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 4,804 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000148 · wk-form4_1763418432.xml · derivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,454 Underlying: Class A Common Stock · 4,804 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest as to 6.25% of the underlying shares on May 15, 2025 and the remaining 93.75% of the underlying shares to vest in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock units vest as to 6.25% of the underlying shares on May 15, 2025 and the remaining 93.75% of the underlying shares to vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| November 15, 2025 Filed Nov 17, 2025 17:27 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 1,719 | $2.97 | $5,105.43 |
DisclosureSEC source: 0001809519-25-000148 · wk-form4_1763418432.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,492 Read SEC document |
| November 15, 2025 Filed Nov 17, 2025 17:27 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 4,804 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-25-000148 · wk-form4_1763418432.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 158,211 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| November 08, 2025 Filed Nov 10, 2025 17:14 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 12,662 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000146 · wk-form4_1762812871.xml · derivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,977 Underlying: Class A Common Stock · 12,662 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock units vest as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| November 08, 2025 Filed Nov 10, 2025 17:14 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 4,531 | $3.11 | $14,091.41 |
DisclosureSEC source: 0001809519-25-000146 · wk-form4_1762812871.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,407 Read SEC document |
| November 08, 2025 Filed Nov 10, 2025 17:14 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 12,662 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-25-000146 · wk-form4_1762812871.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 157,938 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| September 08, 2025 Filed Sep 8, 2025 17:06 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 2,232 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000124 · wk-form4_1757365579.xml · derivative · entry 6 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,323 Underlying: Class A Common Stock · 2,232 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F3 · derivative.exercise_date: The restricted stock unit award will vest as to 6.25% of the underlying shares on June 8, 2024 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. F3 · derivative.expiration_date: The restricted stock unit award will vest as to 6.25% of the underlying shares on June 8, 2024 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| September 08, 2025 Filed Sep 8, 2025 17:06 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 10,201 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000124 · wk-form4_1757365579.xml · derivative · entry 5 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,803 Underlying: Class A Common Stock · 10,201 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| September 08, 2025 Filed Sep 8, 2025 17:06 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 799 | $4.00 | $3,196.00 |
DisclosureSEC source: 0001809519-25-000124 · wk-form4_1757365579.xml · nonDerivative · entry 4 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,276 Read SEC document |
| September 08, 2025 Filed Sep 8, 2025 17:06 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 2,232 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-25-000124 · wk-form4_1757365579.xml · nonDerivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,075 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| September 08, 2025 Filed Sep 8, 2025 17:06 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 3,650 | $4.00 | $14,600.00 |
DisclosureSEC source: 0001809519-25-000124 · wk-form4_1757365579.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,843 Read SEC document |
| September 08, 2025 Filed Sep 8, 2025 17:06 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 10,201 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-25-000124 · wk-form4_1757365579.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,493 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| August 15, 2025 Filed Aug 15, 2025 18:36 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 4,804 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000121 · wk-form4_1755297402.xml · derivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,258 Underlying: Class A Common Stock · 4,804 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest as to 6.25% of the underlying shares on May 15, 2025 and the remaining 93.75% of the underlying shares to vest in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock units vest as to 6.25% of the underlying shares on May 15, 2025 and the remaining 93.75% of the underlying shares to vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| August 15, 2025 Filed Aug 15, 2025 18:36 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 1,719 | $3.54 | $6,085.26 |
DisclosureSEC source: 0001809519-25-000121 · wk-form4_1755297402.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,292 Read SEC document |
| August 15, 2025 Filed Aug 15, 2025 18:36 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 4,804 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-25-000121 · wk-form4_1755297402.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,011 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| August 08, 2025 Filed Aug 8, 2025 17:15 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 12,663 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000119 · wk-form4_1754687697.xml · derivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,639 Underlying: Class A Common Stock · 12,663 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock units vest as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| August 08, 2025 Filed Aug 8, 2025 17:15 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 4,531 | $3.47 | $15,722.57 |
DisclosureSEC source: 0001809519-25-000119 · wk-form4_1754687697.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,207 Read SEC document |
| August 08, 2025 Filed Aug 8, 2025 17:15 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 12,663 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-25-000119 · wk-form4_1754687697.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,738 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| June 08, 2025 Filed Jun 9, 2025 18:15 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 2,232 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000097 · wk-form4_1749507330.xml · derivative · entry 6 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,555 Underlying: Class A Common Stock · 2,232 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F3 · derivative.exercise_date: The restricted stock unit award will vest as to 6.25% of the underlying shares on June 8, 2024 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. F3 · derivative.expiration_date: The restricted stock unit award will vest as to 6.25% of the underlying shares on June 8, 2024 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| June 08, 2025 Filed Jun 9, 2025 18:15 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 10,201 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000097 · wk-form4_1749507330.xml · derivative · entry 5 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,004 Underlying: Class A Common Stock · 10,201 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| June 08, 2025 Filed Jun 9, 2025 18:15 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 799 | $4.08 | $3,259.92 |
DisclosureSEC source: 0001809519-25-000097 · wk-form4_1749507330.xml · nonDerivative · entry 4 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,075 Read SEC document |
| June 08, 2025 Filed Jun 9, 2025 18:15 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 2,232 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-25-000097 · wk-form4_1749507330.xml · nonDerivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,874 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| June 08, 2025 Filed Jun 9, 2025 18:15 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 3,650 | $4.08 | $14,892.00 |
DisclosureSEC source: 0001809519-25-000097 · wk-form4_1749507330.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,642 Read SEC document |
| June 08, 2025 Filed Jun 9, 2025 18:15 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 10,201 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-25-000097 · wk-form4_1749507330.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,292 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| May 15, 2025 Filed May 15, 2025 17:46 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 4,804 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000079 · wk-form4_1747345610.xml · derivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,062 Underlying: Class A Common Stock · 4,804 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest as to 6.25% of the underlying shares on May 15, 2025 and the remaining 93.75% of the underlying shares to vest in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock units vest as to 6.25% of the underlying shares on May 15, 2025 and the remaining 93.75% of the underlying shares to vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| May 15, 2025 Filed May 15, 2025 17:46 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 1,719 | $4.27 | $7,340.13 |
DisclosureSEC source: 0001809519-25-000079 · wk-form4_1747345610.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,091 Read SEC document |
| May 15, 2025 Filed May 15, 2025 17:46 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 4,804 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-25-000079 · wk-form4_1747345610.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,810 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| May 08, 2025 Filed May 8, 2025 18:16 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 12,663 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000077 · wk-form4_1746742565.xml · derivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,302 Underlying: Class A Common Stock · 12,663 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock units vest as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| May 08, 2025 Filed May 8, 2025 18:16 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 4,531 | $3.79 | $17,172.49 |
DisclosureSEC source: 0001809519-25-000077 · wk-form4_1746742565.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,006 Read SEC document |
| May 08, 2025 Filed May 8, 2025 18:16 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 12,663 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-25-000077 · wk-form4_1746742565.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,537 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| March 08, 2025 Filed Mar 10, 2025 17:06 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 2,233 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000050 · wk-form4_1741640810.xml · derivative · entry 6 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,787 Underlying: Class A Common Stock · 2,233 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F3 · derivative.exercise_date: The restricted stock unit award will vest as to 6.25% of the underlying shares on June 8, 2024 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. F3 · derivative.expiration_date: The restricted stock unit award will vest as to 6.25% of the underlying shares on June 8, 2024 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.